Upgrade to SI Premium - Free Trial

Form SCHEDULE 13G/A Eloxx Pharmaceuticals, Filed by: Coastlands Capital LP

May 29, 2026 9:55 PM





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,074,935 shares outstanding as of May 27, 2026 as provided by the Issuer to the Reporting Persons and (B) 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, which reflects the beneficial ownership limitation of 4.99%. Excludes pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,074,935 shares outstanding as of May 27, 2026 as provided by the Issuer to the Reporting Persons and (B) 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, which reflects the beneficial ownership limitation of 4.99%. Excludes pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,074,935 shares outstanding as of May 27, 2026 as provided by the Issuer to the Reporting Persons and (B) 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, which reflects the beneficial ownership limitation of 4.99%. Excludes pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,074,935 shares outstanding as of May 27, 2026 as provided by the Issuer to the Reporting Persons and (B) 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, which reflects the beneficial ownership limitation of 4.99%. Excludes pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer.


SCHEDULE 13G




Comment for Type of Reporting Person: Consists of 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held directly by Coastlands Capital Partners LP. The calculation of the beneficial ownership of the Reporting Persons is based on (A) 5,074,935 shares outstanding as of May 27, 2026 as provided by the Issuer to the Reporting Persons and (B) 266,539 shares of Common Stock issuable upon the exercise of pre-funded warrants held by the Reporting Persons, which reflects the beneficial ownership limitation of 4.99%. Excludes pre-funded warrants held by the Reporting Persons in excess of such beneficial ownership limitation. This Amendment No. 1 constitutes an exit filing for the Reporting Persons, as the Reporting Persons no longer beneficially own more than 5 percent of any class of securities of the Issuer.


SCHEDULE 13G



Coastlands Capital LP
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital LLC
Date:05/29/2026
Coastlands Capital Partners LP
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer of the General Partner, Coastlands Capital GP LLC
Date:05/29/2026
Coastlands Capital GP LLC
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:05/29/2026
Coastlands Capital LLC
Signature:/s/ Mark Shamia
Name/Title:Chief Operating Officer
Date:05/29/2026
Matthew D. Perry
Signature:/s/ Matthew D. Perry
Name/Title:Reporting Person
Date:05/29/2026

Categories

SEC Filings